» Authors » Mauro S Sandrin

Mauro S Sandrin

Explore the profile of Mauro S Sandrin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 360
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Christiansen D, Mouhtouris E, Hodgson R, Sutton V, Trapani J, Ierino F, et al.
Transpl Int . 2019 Jun; 32(11):1203-1215. PMID: 31225919
We have previously reported that ICOS-Ig expressed locally by a PIEC xenograft induces a perigraft cellular accumulation of CD4 CD25 Foxp3 T cells and specific xenograft prolongation. In the present...
2.
Huynh N, Wang K, Yim M, Dumesny C, Sandrin M, Baldwin G, et al.
BMC Cancer . 2017 Jun; 17(1):431. PMID: 28629331
Background: P21-activated kinase 1 (PAK1) stimulates growth and metastasis of colorectal cancer (CRC) through activation of multiple signalling pathways. Up-regulation of CRC stem cell markers by PAK1 also contributes to...
3.
Christiansen D, Mouhtouris E, Ramsland P, Sandrin M
Methods Mol Biol . 2012 May; 885:47-56. PMID: 22565989
Naturally occurring and elicited anti-carbohydrate antibodies play a major role in immune responses to xenografts. The original obstacles associated with the Gal antigen have been largely resolved by the generation...
4.
Lin W, Christiansen D, Fu L, Roberts M, Sandrin M, Ierino F
Nephrology (Carlton) . 2012 Feb; 17(4):415-22. PMID: 22308996
Aim: Immunophenotype peripheral blood T cells from renal transplant recipients (RTR) using cellular markers of regulatory T cells (Tregs) and flow cytometry, including Foxp3, and correlate these findings with clinical...
5.
Hodgson R, Christiansen D, Ziolkowski A, Mouhtouris E, Simeonovic C, Ierino F, et al.
Transplantation . 2011 May; 91(10):1090-7. PMID: 21544030
Background: Blockade of the inducible costimulator (ICOS) pathway has been shown to prolong allograft survival; however, its utility in xenotransplantation is unknown. We hypothesize that local expression of ICOS-Ig by...
6.
Bishop G, Ierino F, Sharland A, Hall B, Alexander S, Sandrin M, et al.
Transplantation . 2011 May; 91(10):1065-74. PMID: 21544029
Long-term acceptance of transplanted organs without requirement for indefinite immunosuppression remains the ultimate goal of transplant clinicians and scientists. This clinical state of allograft acceptance termed "operational tolerance" has been...
7.
Diswall M, Gustafsson A, Holgersson J, Sandrin M, Breimer M
Xenotransplantation . 2011 Feb; 18(1):28-39. PMID: 21342285
Background: αGal-specific lectins, monoclonal and polyclonal antibodies (Abs) are widely used in xenotransplantation research. Immunological assays such as immunohistochemistry, flow cytometry, Western blot and thin layer chromatography are often the...
8.
Christiansen D, Vaughan H, Milland J, Miland J, Dodge N, Mouhtouris E, et al.
Immunol Cell Biol . 2011 Feb; 89(4):502-10. PMID: 21283109
Naturally occurring anti-carbohydrate antibodies play a major role in both the innate and adaptive immune responses. To elicit an anti-carbohydrate immune response, glycoproteins can be processed to glycopeptides and presented...
9.
Agostino M, Sandrin M, Thompson P, Farrugia W, Ramsland P, Yuriev E
Expert Opin Biol Ther . 2011 Jan; 11(2):211-24. PMID: 21219238
Introduction: The existence of specific carbohydrates on the surface of a wide range of cells provides the opportunity for the development of highly targeted therapeutic agents. The potential applications of...
10.
Agostino M, Sandrin M, Thompson P, Ramsland P, Yuriev E
Biopolymers . 2010 Jun; 96(2):193-206. PMID: 20564023
Carbohydrate-antibody interactions mediate many cellular processes and immune responses. Carbohydrates expressed on the surface of cells serve as recognition elements for particular cell types, for example, in the ABO(H) blood...